Kevin Alexander
@KMAlexanderMD
Followers
771
Following
791
Media
3
Statuses
252
Physician-scientist, advanced heart failure and transplant cardiologist, amyloidosis specialist
Stanford, CA
Joined April 2018
RT @JeffTeuteberg: 🥳🙌 Congratulations to @Stanford_HF's graduating HF fellows Ibrahim Alfaris, Leon Zhou, and Ricardo Chi Li! Great work a….
0
3
0
RT @StanfordDeptMed: New research featuring #StanDOM's @graciafahed, @KMAlexanderMD, @Ron_Witteles, Francois Haddad & Gabriela Spencer-Boni….
0
3
0
RT @mvaduganathan: 👑 @MariannaFonta11 new data at #HeartFailure2025 from #ATTRibuteCM. Exploring effects of acoramidis on functional capac….
0
1
0
RT @mvaduganathan: How do patients with #ATTRCM die? . New insights from #ATTRibuteCM at #HeartFailure2025 @KMAlexanderMD @MasriAhmadMD #Me….
0
3
0
RT @mvaduganathan: New data from #ATTRibuteCM presented at #HeartFailure2025 . Intriguing analysis by @KMAlexanderMD High-affinity TTR sta….
0
6
0
RT @JACCJournals: Establishing repeatability, reproducibility, & accuracy of imaging metrics is paramount for use in pivotal multicenter #a….
0
9
0
RT @KiranKhush1: Incredibly proud of the @Stanford_HF team, with so many impactful presentations at #ISHLT2025. Honored to work with such….
0
8
0
RT @cardiomet_CE: 19a) A final analysis from #ATTRibute_CM, led by @KMAlexanderMD, evaluated the stability & improvement in #NYHA class on….
0
1
0
RT @JLRosenthal: Please share this exciting and interactive Amyloid case based seminar w/your fellow Amyloid champions and trainees. @Bre….
0
13
0
RT @graciafahed: Systemic efforts are needed for early diagnosis, enabling all populations to benefit from breakthrough treatments. For mo….
0
1
0
RT @graciafahed: 🫀Therapeutic options for ATTR-CM are expanding rapidly, yet diagnostic delays remain significant.👇Our latest @JACCJournals….
0
7
0
RT @StanfordCME: Why is heart failure & cardiac amyloidosis under-diagnosed in African American communities? 🫀 Dr. Alexander discusses the….
0
2
0
RT @JLRosenthal: And then there were 3! @Ron_Witteles @MasriAhmadMD @MarthaGrogan1 @maz_hanna @BrettSperryMD @KMAlexanderMD @YevgeniyBr @M….
0
13
0
RT @MelissaLyleMD: I’m excited to be speaking at the AHA’s National AL-Amyloidosis Patient-to-Provider Connection Forum March 12th! Hope yo….
0
1
0
RT @StanfordCME: Why is heart failure & cardiac amyloidosis under-diagnosed in African American communities? 🫀 Dr. Alexander discusses the….
0
3
0
RT @gmvasilakis: 🚨 Acoramidis ⬇️⬇️ Hospitalizations in #ATTR cardiomyopathy 🫀. Part 2 of my discussion with Dr. Kevin Alexander is live! (a….
0
7
0
RT @StanfordCME: Did you know African American communities face a higher risk of transthyretin cardiac amyloidosis, often misdiagnosed as h….
0
1
0
RT @dr_pavia: Study can be found here: (15/15).@Paul_P_Cheng @Ron_Witteles @KMAlexanderMD @MarthaGrogan1 @ThibaudDa….
0
5
0
RT @Ron_Witteles: Excited to see the second ever drug approval for #ATTR cardiomyopathy. Another triumph for science 🧪 and great news for p….
0
14
0
RT @graciafahed: And it’s a wrap! #AHA2024 #Chicago.Had the pleasure to present our work on ATTR genetic carriers 🫀 & reconnect with friend….
0
4
0